TNFSF10 and melanoma: Treatment of different melanoma cell lines (A-375, Mel-HO, SK-Mel-13, SK-Mel-28, Mel-2a, and MeWo) showing high levels of IKCa expression with the specific inhibitor TRAM-34 decreased proliferation and sensitized cells to death receptor ligand TRAIL-induced apoptosis, partially overcoming TRAIL resistance [232].